Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-27
DOI
10.1186/s12933-021-01339-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study
- (2020) Yi-Chih Hung et al. Cardiovascular Diabetology
- Pioglitazone Therapy in Patients With Stroke and Prediabetes
- (2019) J. David Spence et al. JAMA Neurology
- Potential New Horizons for the Prevention of Cerebrovascular Diseases and Dementia
- (2019) Leonardo Pantoni JAMA Neurology
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
- (2019) Min-Hee Woo et al. Cardiovascular Diabetology
- Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke
- (2019) Karen C. Johnston et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
- (2018) Cheng-Wei Chan et al. Cardiovascular Diabetology
- Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017
- (2018) Thomas R. Einarson et al. Cardiovascular Diabetology
- SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
- (2018) Michaël J.B. van Baar et al. DIABETES CARE
- The low dose (7.5 mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure
- (2017) Hiroki Adachi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Insulin resistance in ischemic stroke
- (2017) Xiao-Ling Deng et al. METABOLIC BRAIN DISEASE
- Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke
- (2017) Jinkwon Kim et al. STROKE
- Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
- (2016) Silvio E. Inzucchi et al. DIABETES CARE
- Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes
- (2016) Shih-Wei Lai et al. MEDICINE
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
- (2015) Anoop Dinesh Shah et al. Lancet Diabetes & Endocrinology
- Risk of Stroke with Thiazolidinediones: A Ten-Year Nationwide Population-Based Cohort Study
- (2013) Chien-Jung Lu et al. CEREBROVASCULAR DISEASES
- In Vivo Actions of Peroxisome Proliferator-Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
- (2013) R. Eldor et al. DIABETES CARE
- Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
- (2012) J. Rosenstock et al. DIABETES CARE
- Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: A preclinical stroke trial
- (2012) Juraj Culman et al. EXPERIMENTAL NEUROLOGY
- Obesity
- (2012) Walter N. Kernan et al. STROKE
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Resistance a Possible Causal and Treatable Risk Factor for Ischemic Stroke
- (2010) Graeme J. Hankey et al. ARCHIVES OF NEUROLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started